Growth Synergy DSI recently merged with ProductLife Group, creating a broader regulatory and compliance services platform. This presents cross-sell opportunities for PLG clients needing CMC, pharmacovigilance, RIM and device regulatory support, as well as DSIs specialized drug development expertise.

Global Capabilities As part of a global life sciences network, DSI can position itself to win multinational projects, offering harmonized regulatory strategies and post-approval compliance services across regions, appealing to mid to large biotech and pharma companies expanding internationally.

CMC Expertise DSI’s strong, hands-on CMC consulting and risk-based submission strategies align with sponsors seeking efficient development timelines. This core competency can be packaged as a fast-track CMC solution for drug development programs targeting accelerated approvals.

Pharmacovigilance Push With enhanced pharmacovigilance capabilities within PLG, there is an opportunity to upsell QPPV services, safety database validation, and regulatory reporting solutions to clients needing scalable post-approval safety compliance.

Mid-Market Focus Revenue range and employee size indicate DSI targets mid-market biopharma and emerging pharma companies. Craft bundled offerings combining regulatory affairs, quality, and advisory services tailored to smaller teams with growing development portfolios.